Prevention of Pressure Injury (PI) in Hospitalised Infants, Children, and Young People (CYP) (Aged 0-19 Years)
CYPPI
1 other identifier
observational
542
1 country
1
Brief Summary
What is the problem? Children and young people admitted to hospital can sometimes be harmed by what is called a pressure injury. Pressure injuries are sores (ulcers) that happen on areas of the skin that are under pressure. The pressure can come from lying in bed, sitting in a wheelchair, or wearing a cast for a long time. They usually form on bony parts of the body, such as the heels, elbows, hips, and tailbone. This can be uncomfortable for the patient and distressing for their families. As well, it means that more staff and treatments are needed for the patient. What is known? There is a difference in pressure injury seriousness for infants and children with dark skin tones to those without. Pressure injury care for hospitalised patients starts with an assessment using a tool. In the past, the assessment tools were developed without consideration for differences due to skin tone. This means that the current tools may not be the best way to identify pressure injury for dark skin tones. Healthcare professionals need to make sure that tools are fit for purpose for all. What are investigators going to do? Investigators will work with healthcare professionals, children, and parents together to develop and test the existing pressure injury risk assessment tool for use with dark skin tones. This study is a result of care priority discussions with parents and children. It came from the patients and will benefit the patients. Children, young people, and parents will be involved throughout to ensure their voices are heard. How are investigators going to do it? Investigators will:
- 1.Look at existing information about pressure injury for children with darker skin tones. If required, investigators will change and increase the accuracy of the existing tool.
- 2.Test the modified risk assessment tool at 10 children's hospitals in the UK. Investigators will do this to see if it can distinguish hospitalised children with dark skin tones, at high or low risk of pressure injury development during their hospital stay.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
September 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 16, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 16, 2026
December 26, 2025
October 1, 2025
10 months
September 19, 2025
December 10, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Total PI risk assessment score measured using the BRADEN-QD scale with or without additional items
Total PI risk assessment score. The scale uses a 0 to 20 point scale, with scores of 13 or higher indicating a patient is at risk for a PI
up to 4 weeks
Pressure Injury development
Developing a pressure injury while in hospital.
up to 4 weeks
Secondary Outcomes (4)
Length of hospital stay (LOS)
up to 24 weeks
Morbidity
Up to 4 weeks
Mortality
up to 4 weeks
Economic impact
Up to 4 weeks
Eligibility Criteria
Phase 1: Healthcare professionals who look after infants, children and young people in hospital (children's nurses and doctors from various clinical areas, dermatologist, tissue viability practitioners and clinical educators); parents/ guardians of children who have a dark skin tone, have developed a pressure injury(s) while in hospital before, and children and young people with dark skin tones who have developed pressure injury(s) while in hospital before. Phase 2: Children and young people with dark skin tone admitted to hospital.
You may qualify if:
- Phase 1
- HCP participants:
- Experts (e.g. tissue viability practitioners, dermatologist)
- HCP looking after hospitalised infants and CYP
- Able to give consent
- Parent/ guardian participants:
- Parents/ guardians of infants and CYP admitted to hospital with or developed PI
- Parent/ guardian of a CYP under 19 years of age with dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI.
- Able to give consent
- CYP participants:
- Age 10 - 19
- Dark skin tone according to Fitzpatrick Classification of Skin Types III, IV, V or VI.
- Able to gain consent
- Able to provide assent with parental consent
- Developed PI during hospitalisation Phase 2 Hospitalised infants and CYP participants
- +1 more criteria
You may not qualify if:
- Phase1:
- HCP participants:
- HCP not working with hospitalised infants and CYP.
- Unable to provide consent.
- Parents participants:
- Parents of hospitalised infants and CYP with no PI.
- Unable to gain consent
- CYP participants:
- Not able to provide consent
- CYP with no PI during hospitalisation period Phase 2
- \. Admitted to hospital for less than 24 hrs 2. Unable to gain consent 3. Fitzpatrick Classification of Skin Types I, II or III
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nottingham University Hospitals NHS Trustlead
- University of Leicestercollaborator
- University of Surreycollaborator
Study Sites (1)
Nottingham University Hospital
Nottingham, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Takawira C Marufu, Phd
Nottingham University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2025
First Posted
December 26, 2025
Study Start
July 30, 2025
Primary Completion (Estimated)
May 16, 2026
Study Completion (Estimated)
May 16, 2026
Last Updated
December 26, 2025
Record last verified: 2025-10